Early-onset group B streptococcal disease in the era of maternal screening.
about
Screening for group B Streptococcus in pregnant women: a systematic review and meta-analysisGroup B Streptococcus vaccine: state of the artAntibiotic use and misuse during pregnancy and delivery: benefits and risksRisk assessment in neonatal early onset sepsisNeonatal group B streptococcal disease: incidence, presentation, and mortality.Evaluation of a novel real-time PCR test based on the ssrA gene for the identification of group B streptococci in vaginal swabs.Contribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain.Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of glyceraldehyde-3-phosphate dehydrogenase from Streptococcus agalactiae NEM316.Intrapartum PCR assay versus antepartum culture for assessment of vaginal carriage of group B streptococci in a Danish cohort at birth.Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in miceReal-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus.Improving perinatal Group B streptococcus screening with process indicators.Temporal characterization of carrot broth-enhanced real-time PCR as an alternative means for rapid detection of Streptococcus agalactiae from prenatal anorectal and vaginal screeningsReal-time polymerase chain reaction for the rapid detection of group B streptococcal colonization in neonatesContinued early onset group B streptococcal infections in the era of intrapartum prophylaxis.Neonatal infections in Saudi Arabia: association with C-reactive protein, CRP -286 (C>T>A) gene polymorphism and IgG antibodiesGroup B streptococcus and early-onset sepsis in the era of maternal prophylaxis.DNA microarray-based typing of Streptococcus agalactiae isolates.Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants.Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains.Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease.Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease.Evaluation of a rapid, real-time intrapartum group B streptococcus assayType IV neonatal early-onset group B streptococcal disease in a United States hospital.Use of the complete blood cell count in early-onset neonatal sepsisGroup B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis.Incidence of maternal GBS colonization and neonatal GBS disease among very low birth weight Polish neonatesEvaluation of the Cepheid Xpert GBS assay for rapid detection of group B Streptococci in amniotic fluids from pregnant women with premature rupture of membranes.Comparison of carrot broth- and selective Todd-Hewitt broth-enhanced PCR protocols for real-time detection of Streptococcus agalactiae in prenatal vaginal/anorectal specimens.Invasive group B streptococcal infections in infants, France.In utero ethanol exposure impairs defenses against experimental group B streptococcus in the term Guinea pig lung.Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China.Adherence to perinatal group B streptococcal prevention guidelines.Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines.Lactobacillus fermentum ATCC 23271 Displays In vitro Inhibitory Activities against Candida spp.Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis.2010 perinatal GBS prevention guideline and resource utilization.Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.Lactobacilli at the front line of defense against vaginally acquired infections.An update on vaccination against group B streptococcus.
P2860
Q22241470-0F81C70F-C1AD-4E32-A5CF-47B01E6E265DQ26796438-059B2536-66D5-4C0F-9E7B-48BB1CC42CA1Q27003944-9B9DF821-14C8-45DB-A7E8-6AFCFDEC9131Q27026247-1FDC3733-250A-4AC5-9D5C-0D04471BF254Q33378153-084FF0EB-C897-41FD-9617-66E84DD05381Q33500338-DB9855A7-5B7D-4F4E-8FF9-C42795F01B67Q33868597-9E20FB80-DB89-4905-B4B9-342E7F6BEB5CQ33872851-6E57822D-E110-4587-A3D5-C44EE2832213Q33873880-81D70162-3ABE-4E82-B3A8-53199BF3102CQ34084719-33870CD9-C41F-4CD1-BDAE-08CEA0C55C01Q34120557-6F3BC3C5-A697-427C-B756-4AC0CE040029Q34171416-57AF68D0-0A52-45D6-BBA6-C80181788C0DQ34433165-64A7A6DD-A28C-499A-9825-ED0DD1424AB7Q34806368-10A0ED0D-0407-4E10-81FB-AB9608981E31Q34808968-42BA1EF3-ED3F-4630-B3D8-1F7AEBF4292BQ34939198-228DAF49-35D2-4E4B-ABAE-3847B7FE3581Q34985330-14793BAA-5F3C-4089-8874-E72EFCD6607EQ35036001-2751DE84-8B32-4D69-86E6-8F73EFE219ACQ35056256-3E9C8599-84CD-4171-B064-DE79AEA73486Q35136415-561C7EFF-344F-46A1-BF71-9D74310294DBQ35155411-2AC34EF8-F9BE-4A75-9CB5-38E647F43CB3Q35171056-E9C6DDF9-0F09-4553-9DA6-51F01033005CQ35552493-113AC488-BB82-4A1E-A342-A5FD6738975FQ35784351-85E43EA4-BD48-41DE-80E5-68F8446BA8ACQ36103569-976D420A-FFC3-4A9E-B3B9-37DDF2D5A1DCQ36609479-DC2D0FB3-1F4C-48C1-936B-F8CF98D43EE0Q36772792-59C1E6B7-BAA4-4B2C-992B-CE4A525D5CE0Q36884412-39138B97-E8EE-4A4F-93EF-7B04BFFB6478Q36957979-565DD845-741E-47EF-A9C8-0742172B84E1Q37028456-CAC1C82E-76EF-4707-96B4-339AFA94DA78Q37142998-B21C3E2F-DED9-46F1-B1C8-ABF798ECAA87Q37172465-53FF4121-A14A-433D-B300-7E27D6E4D8C1Q37173310-900584E8-C7A6-40AF-8A8B-35695A6B7587Q37195675-23C13D6C-3668-4742-B473-8EA838C98968Q37370353-F1B2343D-E2C7-40DD-976C-132630C354D0Q37439746-1486FF3F-32DC-45B2-823B-1B6AAABDA644Q37522924-2A3E7B31-E65F-432C-A823-4A7524EDB6EDQ37614189-C31231BD-B941-405B-B48E-85293DDA9BC7Q37876417-C1BB00C6-8909-46A8-964E-BCE33026004AQ37878487-5ED22244-F84A-4697-B884-7D296BC73CD5
P2860
Early-onset group B streptococcal disease in the era of maternal screening.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Early-onset group B streptococcal disease in the era of maternal screening.
@ast
Early-onset group B streptococcal disease in the era of maternal screening.
@en
type
label
Early-onset group B streptococcal disease in the era of maternal screening.
@ast
Early-onset group B streptococcal disease in the era of maternal screening.
@en
prefLabel
Early-onset group B streptococcal disease in the era of maternal screening.
@ast
Early-onset group B streptococcal disease in the era of maternal screening.
@en
P2093
P356
P1433
P1476
Early-onset group B streptococcal disease in the era of maternal screening.
@en
P2093
Eric C Eichenwald
Karen M Puopolo
Lawrence C Madoff
P304
P356
10.1542/PEDS.2004-2275
P407
P577
2005-05-01T00:00:00Z